satoru watanabe - Infectious Diseases

Author Information

Satoru Watanabe is a prominent researcher in the field of Infectious Diseases, currently affiliated with the Program in Emerging Infectious Diseases at Duke-NUS Medical School in Singapore. His work primarily focuses on the study of viral infections, including dengue, Zika, and SARS-CoV-2, utilizing both experimental models and clinical insights to advance understanding and treatment of these diseases.

Research Contributions

Satoru Watanabe has made significant contributions to the field of infectious diseases through his extensive research on viral pathogens such as dengue and Zika viruses. His work includes the study of maternal-fetal transmission of dengue virus, the metabolic impacts of Zika virus on fetal development, and the immune responses elicited by vaccines. Additionally, he has explored innovative imaging techniques for studying viral replication and the stability of viral proteins, contributing to the development of effective vaccines and therapeutic strategies.

Aliases

There are no aliases provided for Satoru Watanabe, indicating that he is primarily known by his full name in academic publications.

Publication and Citation Metrics

Metric	Value
Citation Count	2369
H-Index	26
Paper Count	68

Publications:

Experimental evidence for a high rate of maternal-fetal transmission of dengue virus in the presence of antibodies in immunocompromised mice

DOI: 10.1016/j.ebiom.2022.103930

Year: 2022

Secreted dengue virus NS1 is predominantly dimeric and in complex with high-density lipoprotein

DOI: 10.1101/2022.04.06.487425

Year: 2022

A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection

DOI: 10.1016/j.antiviral.2021.105138

Year: 2021

Dysregulated metabolism underpins Zika-virus-infection-associated impairment in fetal development

DOI: 10.1016/j.celrep.2021.110118

Year: 2021

Dysregulated Metabolism Underpins Zika Virus Infection-Associated Impairment in Fetal Development

DOI: 10.2139/ssrn.3890378

Year: 2021

In Vitro and In Vivo Stability of P884T, a Mutation that Relocalizes Dengue Virus 2 Non-structural Protein 5.

DOI: 10.1021/acsinfecdis.1c00441

Year: 2021

Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection

DOI: 10.1016/j.ebiom.2020.103028

Year: 2020

Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers for In Situ Live-Cell Molecular Imaging of Dengue Virus Replication

DOI: 10.3390/ijms21239260

Year: 2020

Protective Immune Responses Elicited by Deglycosylated Live-Attenuated Simian Immunodeficiency Virus Vaccine Are Associated with IL-15 Effector Functions

DOI: 10.4049/jimmunol.1901431

Year: 2020

18F-Fluorodeoxyglucose Positron Emission Tomography as a window into human dengue pathophysiology.

DOI: 10.1016/j.antiviral.2020.104991

Year: 2020

How Does the Immune System Respond to Infections?

How Does Inflammation Help in Fighting Infections?

How is Schistosomiasis Diagnosed?

What are Structural Proteins?

Why is it Important in Infectious Diseases?

How Does Surveillance Help in Managing Infectious Diseases?

How Does WHO Ensure Compliance with Health Regulations?

When are Quarantine and Isolation Used?

What Are the Side Effects of Antimalarial Drugs?

What Are the Challenges in Genomic Studies of Infectious Diseases?

Partnered Content Networks

Relevant Topics